Binimetinib, an inhibitor of MEK1/2 (Figure 6A), can enhance the effect of cetuximab in neuroblastoma RAS viral oncogene homolog (NRAS)-mutant colorectal cancer cells [99]. Here, NRAS is linked to colorectal cancer.